DigestRedComo funciona
Red
/
Empresas
Te
No verificado

Teva Pharmaceutical Industries Limited

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaMedicina - VariosSalud

6 Comunicados de prensa

Ver todos los comunicados de prensa
25/07/2024
Salud
Biotecnología
Sanidad
Medicina - Varios
Farmacéutica
Mercado laboral
Industria
Teva and Sanofi Announce Accelerated Timeline for Anti-TL1A Phase 2b Program in Patients with Inflammatory Bowel Disease
Fuente
Teva Pharmaceutical Industries Limited
Editor
Business Wire
1.00
0
18/07/2024
Biotecnología
Sanidad
Salud
Farmacéutica
Medicina - Varios
Industria
Teva Announces First Phase 3 Evidence of Efficacy and Safety of an Anti-CGRP Monoclonal Antibody in Children in AJOVY® (fremanezumab) SPACE Trial for Prevention of Episodic Migraine
Fuente
Teva Pharmaceutical Industries Limited
Editor
Business Wire
1.00
0
02/07/2024
Web y redes sociales
Telefonía
Finanzas
Mercado de valores
Biotecnología
Sanidad
Farmacéutica
Salud
Teva to Host Conference Call to Discuss Second Quarter 2024 Financial Results at 8 a.m. ET on July 31, 2024
Fuente
Teva Pharmaceutical Industries Limited
Editor
Business Wire
1.00
0
28/06/2024
Eventos
Industria
Biotecnología
Salud
Farmacéutica
Medicina - Varios
New AJOVY® (fremanezumab) Migraine Prevention Data Challenges Treatment Pauses
Fuente
Teva Pharmaceutical Industries Limited
Editor
Business Wire
1.00
0
25/06/2024
Mercado laboral
Biotecnología
Salud
Farmacéutica
Teva Reaches Agreement With the Israel Tax Authority to Resolve All Pending Litigation for the Company's Taxable Years 2008-2020
Fuente
Teva Pharmaceutical Industries Limited
Editor
Business Wire
1.00
0
03/05/2024
Medios de comunicación
Marketing
Comunicación
Medicina - Varios
Multimedia
Teva to Present at the 2024 Bank of America Healthcare Conference
Fuente
Teva Pharmaceutical Industries Limited
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0